Rebecca Martin, PhD
Rebecca Martin received her Ph.D. in Microbiology and Immunology in 2014 from Virginia Commonwealth University. Her Ph.D. thesis focused on characterizing the novel interaction between myeloid-derived suppressor cells and mast cells in the context of tumor and helminth infection. With an interest in research and teaching, she entered the IRACDA program at Virginia Commonwealth University in 2014. She began working on the B1 cell, investigating it as a source of natural IgE that leads to reduced immune action against parasitic infection with Dr. Daniel Conrad. In March 2016, her F32 fellowship was funded to continue this research. Dr. Martin has eight publications, six of them first author. She spent last summer presenting her data across the country at two national conferences as well as the International Congress of Immunology in Melbourne, Australia. Overall, she hopes to harness “benign” IgE, as a mechanism to block mast cell-mediated allergic disease.